From: Clinical outcomes in patients co-infected with COVID-19 and Staphylococcus aureus: a scoping review
 | Total (%) |
---|---|
Gender | |
 Male | 75 (65.3 ) |
 Female | 37 (32.1) |
 Unspecified | 3 (2.6) |
Staphylococcal Species | |
 MSSA | 59 (51.3) |
 MRSA | 57 (49.6) |
Co-infection | |
Klebsiella pneumoniae | 6 (5.2) |
 Candida spp. | 6 (5.2) |
 Enterococcus spp. | 5 (4.3) |
Hemophilus influenzae | 2 (1.7) |
Escherichia coli | 2 (1.7) |
Proteus mirabilis | 2 (1.7) |
Acinetobacter baumannii | 2 (1.7) |
 Bacillus spp. | 1 (0.9) |
Staphylococcus epidermidis | 1 (0.9) |
 Micrococcus spp. | 1 (0.9) |
 Pseudomonas spp. | 1 (0.9) |
Morganella morganii | 1 (0.9) |
Citrobacter werkmanii | 1 (0.9) |
S. maltophilia | 1 (0.9) |
 Hepatitis C | 1 (0.9) |
 Herpes simplex virus | 1 (0.9) |
 Group B Streptococcus | 1 (0.9) |
 None | 83 (72.2) |
S. Aureus Diagnostic Test | |
 Blood culture | 74 (64.3) |
 Tracheal aspirate | 46 (40.0) |
 Sputum sample | 11 (9.5) |
 Nasal swab | 2 (1.7) |
 Lower respiratory tract sample | 2 (1.7) |
 Chronic carrier | 2 (1.7) |
 Wound culture | 1 (0.9) |
S. aureus Diagnosis | |
 Bacteremia | 74 (63.4) |
 Pneumonia | 64 (55.7) |
 Ventilator-associated | 44 (38.3) |
 Endocarditis/vasculitis | 4 (3.5) |
 Cellulitis | 2 (1.7) |
 Chronic carrier | 2 (1.7) |
 Osteomyelitis | 1 (0.9) |
 Not reported | 2 (1.7) |
S. Aureus Infection Onset | |
 Hospital | 88 (76.5) |
 Community | 19 (16.5) |
 Unclear | 7 (6.1) |
Complications | |
 Sepsis/Systemic Inflammatory Response Syndrome | 27 (23.5) |
 Acute kidney injury | 6 (5.2  |
 Acute respiratory distress syndrome | 5 (4.3) |
 Pneumonia | 5 (4.3) |
 Multi-organ dysfunction/failure | 5 (4.3) |
 Bleeding/coagulopathy | 5 (4.3) |
 Hypoxic respiratory failure | 3 (2.6) |
 Myopathy/neuropathy | 3 (2.6) |
 Abscess formation | 2 (1.7) |
 Confusion and altered mental status | 2 (1.7) |
 Atrial fibrillation | 2 (1.7) |
 Endocarditis | 2 (1.7) |
 Anemia | 1 (0.9) |
 Cardiac arrest | 1 (0.9) |
 Thrombocytopenia | 1 (0.9) |
 Re-amputation | 1 (0.9) |
 Cholestatic liver injury | 1 (0.9) |
 Not reported | 3 (2.6) |
ICU | |
 Yes | 62 (53.9) |
 No | 5 (4.3) |
 Not reported | 48 (41.8) |
Outcome | |
 Death | 71 (61.7) |
 Discharge | 41 (35.7) |
 Hospital | 2 (1.7) |
 Hospice | 1 (0.9) |